Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
15 participants
OBSERVATIONAL
2026-01-05
2027-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Possible Effect of Inspiratory Muscle Training on Inflammation Markers and Oxidative Stress in Childhood Asthma
NCT05296707
The Effect of Yoga on Respiratory Functions, Symptom Control and Life Quality of Asthma Patients
NCT04107415
Development of an Active Video-Based High-Intensity Interval Exercise System in Children With Asthma
NCT06895642
Evaluation of Exercise Capacity and Activity Role Adequacy in Patients With Adult Bronchial Asthma
NCT04051060
Pulmonary Rehabilitation in Asthma Control
NCT03227341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary Rehabilitation Group (PRGr)
Pulmonary Rehabilitation Group (PRGr)
Participant selection for the study was conducted using a purposive sampling approach. All participants experienced inspiratory muscle training for a total of 3 days per week over 8 weeks, with 2 days per week via video conference and 1 day per week as part of a home program. All interviews will be conducted online via a video conference website and recorded using a digital voice recorder. The recorded data will be transcribed word for word in Turkish.
other
Other: Telephone concept elicitation interview
All interview questions are designed to be quite open-ended in order to determine participants' preferences in an unbiased manner (as much as possible). Additional questions will only be used when necessary to ensure that all relevant concepts are covered. Participants will be asked questions about the effects of inspirational muscle training they have previously experienced on their daily lives, coping strategies, and self-management processes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
other
Other: Telephone concept elicitation interview
All interview questions are designed to be quite open-ended in order to determine participants' preferences in an unbiased manner (as much as possible). Additional questions will only be used when necessary to ensure that all relevant concepts are covered. Participants will be asked questions about the effects of inspirational muscle training they have previously experienced on their daily lives, coping strategies, and self-management processes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having been diagnosed with severe persistent, non-allergic asthma by a pulmonologist in accordance with the Global Initiative for Asthma (GINA) guideline criteria,
* Patients with type 2 inflammation markers. According to accepted standards; peripheral eosinophils \<150/µL and/or negative skin prick test and/or total IgE \<30 kU/L
* Bronchodilator response (\>12% or 200 mL improvement in FEV1% predicted following inhalation of 400 mg salbutamol)
* Diagnosis-follow-up period: Patients diagnosed at least 6 months prior, under follow-up and treatment, and/or with controlled asthma
* Having completed the pulmonary rehabilitation program
* Completion of 8 weeks of inspiratory muscle training (IMT)
* Patients who have read, understood, and signed the informed consent form
Exclusion Criteria
* Having a smoking history of more than 10 pack-years or having a history of smoking within 6 months after quitting smoking
* Having received oral corticosteroid treatment in the last 4 weeks,
* Having a Body Mass Index \>35,
* Eosinophilic Granulomatosis Polyangiitis (EGPA) and Allergic Bronchopulmonary Aspergillosis (ABPA),
* Vasculitis,
* History of malignancy,
* Pregnancy,
* Previous lung surgery, use of long-term oxygen therapy
* Having accompanying restrictive lung diseases (advanced kyphoscoliosis, ankylosing spondylitis) and neuromuscular diseases (myastania gravis, muscular dystrophies, myopathies) that will prevent healthy respiratory function testing and rehabilitation.
* Cognitive dysfunction, mental retardation, dementia, or other conditions that make it difficult to follow the protocol,
* Unwillingness to continue participating in the study,
* Communication difficulties or intellectual deficiencies
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Esenyurt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cahidenur Koçak
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Esenyurt University
Istanbul, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMT_Asthma_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.